Loading
J-Pharma Co.,Ltd. is a listed company. Its directors and officers file their transactions with EDINET (Japan FSA). From 18 October 2025 to 18 October 2026, the disclosure feed for J-Pharma Co.,Ltd. logged 3 filings by 3 insiders.
No open-market purchase or sale appears among the filings, only grants, plan transactions and other operations. Such operations are usually part of compensation schedules, which makes them a weaker signal than an open-market trade.
Across the 3,419 companies tracked on its exchange, the median is 3 filings; at 3 filings, this issuer sits right on that mark.
Over the last twelve months, not one insider purchase of J-Pharma Co.,Ltd. stock was filed. Filings reach the EDINET (Japan FSA) feed a median of 6 days after the trade. This delay matters because a trade only becomes useful information once it is public.
Every figure here comes from the filings published by EDINET (Japan FSA) and describes the past, not future prices; it is not investment advice.
This score ranks the purchase within its own market. A position size is suggested only on the venues of the backtested strategy universe; elsewhere, signals stay on watch. Not investment advice.
· cache
3 of 3 declarations
Jay Pharma Co., Ltd. is a company listed on the XTKS market, specializing in the pharmaceutical sector.